From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 854,166 shares, representing 1.57% for $10.18 million under the buyback announced on August 4, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 USD | +11.67% |
|
+18.40% | -21.49% |
07-09 | Evercore ISI Trims Price Target on Health Catalyst to $8 From $9, Maintains Outperform Rating | MT |
07-01 | Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.30% | 384M | |
-14.70% | 61.67B | |
+3.68% | 59.85B | |
+4.34% | 54.56B | |
+7.13% | 43.29B | |
+6.89% | 38.53B | |
+118.07% | 28.93B | |
-9.48% | 28.59B | |
+5.39% | 22.1B | |
+25.08% | 14.74B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Tranche Update on Health Catalyst, Inc.'s Equity Buyback Plan announced on August 4, 2022.